Rights and permissions
About this article
Cite this article
Molgramostim not recommended for febrile neutropenia. Pharmacoecon. Outcomes News 130, 8–9 (1997). https://doi.org/10.1007/BF03272020
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03272020